TipRanks
United Therapeutics (DE:UTH)
FRANKFURT:UTH

Compare United Therapeutics (UTH) vs. Competitors

4 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
United Therapeutics
€447.80
€20.68B
19.04
17.41%
9 Buy
2 Hold
1 Sell
Moderate Buy
Alnylam Pharma
$240.08
$33.02B
37.86
-49.81%
18 Buy
4 Hold
0 Sell
Strong Buy
BioMarin Pharmaceutical
$66.12
$11.61B
154.82
6.53%
17 Buy
5 Hold
0 Sell
Strong Buy
Insmed
$123.89
$24.93B
-26.68
-26.27%
20 Buy
0 Hold
0 Sell
Strong Buy
Jazz Pharmaceuticals
$260.23
$15.03B
15.39
70.20%
18 Buy
1 Hold
0 Sell
Strong Buy
BridgeBio Pharma
$80.40
$12.86B
-18.64
25.11%
16 Buy
1 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
DE:UTH
United Therapeutics
421.40
50.80
13.71%
ALNY
Alnylam Pharma
231.18
-229.81
-49.85%
BMRN
BioMarin Pharmaceutical
58.44
2.87
5.16%
INSM
Insmed
108.59
-44.21
-28.93%
JAZZ
Jazz Pharmaceuticals
233.01
95.80
69.82%
BBIO
BridgeBio Pharma
66.91
13.63
25.58%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts